A major move is in the offing as Seelos Therapeutics Inc. (SEEL) market cap hits 104.04 million

On January 24, 2023, Seelos Therapeutics Inc. (NASDAQ: SEEL) opened at $0.881, higher 0.19% from the last session. During the day, the shares moved up to $0.94 and dropped to $0.8485 before settling in for the closing price of $0.92. Price fluctuations for SEEL have ranged from $0.48 to $1.52 over the past 52 weeks.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Company’s average yearly earnings per share was noted -70.30% at the time writing. With a float of $103.97 million, this company’s outstanding shares have now reached $106.69 million.

Let’s determine the extent of company efficiency that accounts for 16 employees.

Seelos Therapeutics Inc. (SEEL) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Seelos Therapeutics Inc. is 2.98%, while institutional ownership is 28.80%. The most recent insider transaction that took place on Jun 01, was worth 9,789. In this transaction Director of this company bought 16,000 shares at a rate of $0.61, taking the stock ownership to the 16,000 shares. Before that another transaction happened on Mar 31, when Company’s insider bought 66,667 for $0.85, making the entire transaction worth $56,840. This insider now owns 3,281,546 shares in total.

Seelos Therapeutics Inc. (SEEL) Earnings and Forecasts

If we go through the results of last quarter, which was made public on 6/29/2022, the company posted -$0.2 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.14) by -$0.06. This company achieved a return on equity of -220.55. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -70.30% per share during the next fiscal year.

Seelos Therapeutics Inc. (NASDAQ: SEEL) Trading Performance Indicators

Check out the current performance indicators for Seelos Therapeutics Inc. (SEEL). In the past quarter, the stock posted a quick ratio of 1.90.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.78, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.52 in one year’s time.

Technical Analysis of Seelos Therapeutics Inc. (SEEL)

Looking closely at Seelos Therapeutics Inc. (NASDAQ: SEEL), its last 5-days average volume was 0.48 million, which is a drop from its year-to-date volume of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 45.88%. Additionally, its Average True Range was 0.09.

During the past 100 days, Seelos Therapeutics Inc.’s (SEEL) raw stochastic average was set at 32.01%, which indicates a significant decrease from 61.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.69% in the past 14 days, which was lower than the 105.03% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.8898, while its 200-day Moving Average is $0.8716. However, in the short run, Seelos Therapeutics Inc.’s stock first resistance to watch stands at $0.9560. Second resistance stands at $0.9938. The third major resistance level sits at $1.0475. If the price goes on to break the first support level at $0.8645, it is likely to go to the next support level at $0.8108. Should the price break the second support level, the third support level stands at $0.7730.

Seelos Therapeutics Inc. (NASDAQ: SEEL) Key Stats

There are currently 107,168K shares outstanding in the company with a market cap of 104.04 million. Presently, the company’s annual sales total 0 K according to its annual income of -66,050 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -19,604 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

5 Best TaaS Stocks to Buy Right Now

TaaS stock refers to a financial asset sold by...

Fortinet Inc. (FTNT) recently have taken one step ahead with the beta value of 1.14

As on January 25, 2023, Fortinet Inc. (NASDAQ: FTNT) got off with the flyer as it spiked 1.31% to $51.76. During the day, the...

A Little Luck Can Go a Long Way with Rackspace Technology Inc. (RXT) as it 5-day change was 0.35%

Rackspace Technology Inc. (NASDAQ: RXT) started the day on January 25, 2023, with a price decrease of -1.71% at $2.87. During the day, the...

Vascular Biogenics Ltd. (VBLT) 14-day ATR is 0.01: This Stock is Set to Soar Above its Peers

Vascular Biogenics Ltd. (NASDAQ: VBLT) open the trading on January 25, 2023, with great promise as it jumped 1.27% to $0.16. During the day,...


Please enter your comment!
Please enter your name here